AbstractB7-1 and B7-2 are generally thought to have comparable structures and affinities for their receptors, CD28 and CTLA-4, each of which is assumed to be bivalent. We show instead (1) that B7-2 binds the two receptors more weakly than B7-1, (2) that, relative to its CTLA-4 binding affinity, B7-2 binds CD28 2- to 3-fold more effectively than B7-1, (3) that, unlike B7-1, B7-2 does not self-associate, and (4) that, in contrast to CTLA-4 homodimers, which are bivalent, CD28 homodimers are monovalent. Our results indicate that B7-1 markedly favors CTLA-4 over CD28 engagement, whereas B7-2 exhibits much less bias. We propose that the distinct structures and binding properties of B7-1 and B7-2 account for their overlapping but distinct effects...
Considerable progress has been made in characterizing four key sets of interactions controlling anti...
This study compares the biochemical responses in T cells activated with the CD28 ligands B7-1 and B7...
Ligation of CD28 or CTLA-4 with some biologicals can activate T cells due to an unexpected superagon...
B7-1 and B7-2 are generally thought to have comparable structures and affinities for their receptors...
AbstractB7-1 and B7-2 are generally thought to have comparable structures and affinities for their r...
We present a theoretical framework for simulating the synaptic accumulation of the costimulatory mol...
AbstractThe reported affinity differences between CD28 and CTLA-4 binding to B7-1 and B7-2 may serve...
B7-1 and B7-2 are glycoproteins expressed on antigen presenting cells. The binding of these molecule...
SummaryCD28 and CTLA-4 are cell surface cosignaling molecules essential for the control of T cell ac...
AbstractB7-1 (CD80) and B7-2 (CD86) are glycoproteins expressed on antigen-presenting cells. The bin...
Antigen-specific T cell activation requires the engagement of the T cell receptor (TCR) with antigen...
T cell activation requires antigen-independent costimulatory signals induced by the interaction of c...
The importance of the B7/CD28/CTLA-4 molecules has been established in studies of antigen-presenting...
SummaryPathways in the B7:CD28 family of costimulatory molecules regulate T cell activation and tole...
B7 proteins CD80 (B7-1) and CD86 (B7-2) are expressed on most antigen-presenting cells and provide c...
Considerable progress has been made in characterizing four key sets of interactions controlling anti...
This study compares the biochemical responses in T cells activated with the CD28 ligands B7-1 and B7...
Ligation of CD28 or CTLA-4 with some biologicals can activate T cells due to an unexpected superagon...
B7-1 and B7-2 are generally thought to have comparable structures and affinities for their receptors...
AbstractB7-1 and B7-2 are generally thought to have comparable structures and affinities for their r...
We present a theoretical framework for simulating the synaptic accumulation of the costimulatory mol...
AbstractThe reported affinity differences between CD28 and CTLA-4 binding to B7-1 and B7-2 may serve...
B7-1 and B7-2 are glycoproteins expressed on antigen presenting cells. The binding of these molecule...
SummaryCD28 and CTLA-4 are cell surface cosignaling molecules essential for the control of T cell ac...
AbstractB7-1 (CD80) and B7-2 (CD86) are glycoproteins expressed on antigen-presenting cells. The bin...
Antigen-specific T cell activation requires the engagement of the T cell receptor (TCR) with antigen...
T cell activation requires antigen-independent costimulatory signals induced by the interaction of c...
The importance of the B7/CD28/CTLA-4 molecules has been established in studies of antigen-presenting...
SummaryPathways in the B7:CD28 family of costimulatory molecules regulate T cell activation and tole...
B7 proteins CD80 (B7-1) and CD86 (B7-2) are expressed on most antigen-presenting cells and provide c...
Considerable progress has been made in characterizing four key sets of interactions controlling anti...
This study compares the biochemical responses in T cells activated with the CD28 ligands B7-1 and B7...
Ligation of CD28 or CTLA-4 with some biologicals can activate T cells due to an unexpected superagon...